Fuller & Thaler Asset Management Has Decreased By $532,000 Its Progenics Pharmaceutical (PGNX) Position; Eagle Asset Management Has Cut Gentherm (THRM) Stake

April 17, 2018 - By mmahotstuff

Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) Logo

Eagle Asset Management Inc decreased Gentherm Inc (THRM) stake by 23.2% reported in 2017Q4 SEC filing. Eagle Asset Management Inc sold 23,787 shares as Gentherm Inc (THRM)’s stock rose 4.50%. The Eagle Asset Management Inc holds 78,756 shares with $2.50 million value, down from 102,543 last quarter. Gentherm Inc now has $1.34 billion valuation. The stock increased 0.90% or $0.325 during the last trading session, reaching $36.375. About 99,295 shares traded. Gentherm Incorporated (NASDAQ:THRM) has declined 8.68% since April 17, 2017 and is downtrending. It has underperformed by 20.23% the S&P500.

Fuller & Thaler Asset Management Inc decreased Progenics Pharmaceutical Inc (PGNX) stake by 23.95% reported in 2017Q4 SEC filing. Fuller & Thaler Asset Management Inc sold 106,400 shares as Progenics Pharmaceutical Inc (PGNX)’s stock rose 21.67%. The Fuller & Thaler Asset Management Inc holds 337,800 shares with $2.01M value, down from 444,200 last quarter. Progenics Pharmaceutical Inc now has $534.79 million valuation. The stock increased 1.38% or $0.1 during the last trading session, reaching $7.36. About 521,004 shares traded. Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) has declined 32.66% since April 17, 2017 and is downtrending. It has underperformed by 44.21% the S&P500.

Investors sentiment increased to 1.22 in Q4 2017. Its up 0.11, from 1.11 in 2017Q3. It is positive, as 11 investors sold PGNX shares while 40 reduced holdings. 22 funds opened positions while 40 raised stakes. 56.89 million shares or 3.42% less from 58.90 million shares in 2017Q3 were reported. Fisher Asset Limited Liability Corporation reported 0% in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX). Thrivent Finance For Lutherans reported 43,263 shares. Parametric Port Lc has invested 0% in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX). Prudential Fincl reported 112,562 shares stake. Stevens Cap Mngmt Lp accumulated 14,271 shares or 0% of the stock. State Board Of Administration Of Florida Retirement System owns 45,340 shares for 0% of their portfolio. Blair William And Il accumulated 0% or 26,500 shares. Royal Bancorporation Of Canada has invested 0% of its portfolio in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX). State Of Tennessee Treasury Department has invested 0% in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX). California-based Lpl Ltd Co has invested 0% in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX). Jane Street invested in 0% or 12,294 shares. Duncker Streett & holds 0.02% or 14,718 shares in its portfolio. Creative Planning has 0% invested in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX). Millennium Management Limited Liability invested 0% in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX). Opus Point Prtnrs Mngmt Ltd Liability holds 21,782 shares.

Analysts await Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) to report earnings on May, 3. They expect $-0.23 earnings per share, 0.00% or $0.00 from last year’s $-0.23 per share. After $-0.21 actual earnings per share reported by Progenics Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 9.52% negative EPS growth.

Fuller & Thaler Asset Management Inc increased Phibro Animal Health Corp (NASDAQ:PAHC) stake by 66,300 shares to 243,550 valued at $8.16M in 2017Q4. It also upped Quad/Graphics Inc (NYSE:QUAD) stake by 14,800 shares and now owns 52,500 shares. Beazer Homes Usa Inc (NYSE:BZH) was raised too.

Among 5 analysts covering Progenics Pharm (NASDAQ:PGNX), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Progenics Pharm had 11 analyst reports since August 6, 2015 according to SRatingsIntel. The firm has “Buy” rating by Jefferies given on Friday, October 23. The firm has “Buy” rating given on Wednesday, August 9 by Cantor Fitzgerald. The stock of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) earned “Buy” rating by Zacks on Friday, August 7. Needham maintained the stock with “Buy” rating in Tuesday, June 20 report. Needham maintained Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) on Friday, August 7 with “Buy” rating. The stock of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) has “Buy” rating given on Thursday, October 27 by Aegis Capital. Needham upgraded the stock to “Strong Buy” rating in Monday, February 6 report. The firm earned “Buy” rating on Tuesday, September 26 by Jefferies. The firm has “Buy” rating given on Thursday, August 6 by Brean Capital. The stock of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) has “Buy” rating given on Thursday, June 8 by Jefferies.

Eagle Asset Management Inc increased Orbcomm Inc (NASDAQ:ORBC) stake by 117,685 shares to 788,775 valued at $8.03M in 2017Q4. It also upped Ipg Photonics Corp (NASDAQ:IPGP) stake by 22,959 shares and now owns 771,707 shares. Amphenol Corp (NYSE:APH) was raised too.

Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>